BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced that Bruce S. Morra, Ph.D., M.B.A. has been appointed to the Company’s board of directors. Michael N. Taglich, Chairman of SCOLR Pharma’s board of directors, said, “We are pleased to welcome such a widely respected and deeply experienced senior pharmaceutical and healthcare executive to our Board of Directors. Bruce brings to SCOLR years of industry knowledge, proven accomplishments in the development of specialty pharmaceuticals, strategic and marketing leadership, business development and financial expertise, with a particular focus in the area of advanced drug delivery formulations.”
